The Vanderbilt Program for Next Generation Vaccines brings together scientists from the School of Medicine, the College of Arts & Science, and the School of Engineering who create a complex pipeline that integrates structural biology with big data for the discovery of novel antibodies that will spur the development of next-generation vaccines. The program reinvests into two of Vanderbilt’s core strengths that resulted from past investments – the Vanderbilt Vaccine Center (VVC) and the Center for Structural Biology (CSB) – in a new and innovative way.

 

The Vanderbilt Institute for Digital Learning (VIDL) recently partnered with Professors Jens Meiler and James Crowe on a mini-documentary to showcase their research in vaccine development.

 

Supported through the Vanderbilt Trans-Institutional Program (TIP) “Integrating Structural Biology with Big Data for next Generation Vaccines” and National Institutes of Health U01 funding U01 AI150739 “Structure based design of trimer interface epitope focused universal influenza vaccines”

TransInstitutionalPrograms_square_r1NIAID Logo